Asbury Automotive Group, Inc. (ABG)

Executive Summary / Key Takeaways

• Strategic Portfolio Transformation: Asbury's $1.76 billion Herb Chambers acquisition (July 2025) and concurrent $750 million divestiture program represent deliberate portfolio surgery—exiting challenged markets while doubling down on resilient Northeast luxury franchises. This shifts luxury mix from 32% to 36% and accelerates deleveraging toward the sub-3.0x target by summer 2026, creating a more defensible, higher-margin business.

• Technology-Driven Margin Expansion: The Tekion DMS rollout—described as a "heart transplant"—will create SG&A savings by eliminating third-party software costs and boosting productivity. While 2026 bears duplicate system costs, 2027 promises efficiency gains that reinforce ABG's historical leadership in operational metrics, directly supporting its 5.17% operating margin advantage over larger peers.

• Revenue Mix Resilience: Parts & service now generate 47.9% of gross profit (up from 45.8% in 2024) while TCA's F&I platform adds a growing, high-margin revenue stream. This 58% combined gross profit contribution from non-vehicle sales insulates ABG from new car cyclicality and SAAR volatility, transforming it from a cyclical retailer into a recurring-revenue hybrid.

• Valuation Disconnect at Inflection Point: Trading at $195.56 (7.8x P/E, 6.6x P/FCF, 0.97x book) with 13.3% ROE and $465 million free cash flow, ABG trades at a discount to historical auto retail multiples despite superior operational metrics. The market is pricing cyclical risk while ignoring portfolio quality improvements and technology-driven cost savings that should command a premium.

• Critical Execution Variables: The investment thesis hinges on three factors: 1) successful Tekion completion by Q3 2026 without major disruption, 2) achieving sub-3.0x leverage by summer 2026 to enable share repurchases, and 3) maintaining parts & service growth in mid-single digits despite macro headwinds. Failure on any front compresses the margin expansion story and justifies the current discount.

Setting the Scene: The Accordion Business Model

Asbury Automotive Group, incorporated in Delaware in 2002 and headquartered in Duluth, Georgia, has mastered what CEO David Hult calls the "accordion effect"—expanding and contracting operations with disciplined expense control to navigate automotive cycles. This isn't mere cost-cutting; it's a structural advantage that has made ABG the most operationally efficient public auto retailer since 2017, consistently leading peers in SG&A as a percentage of gross profit. In an industry where scale typically drives efficiency, ABG's mid-tier size (223 franchises, 171 locations) paradoxically forces operational excellence that larger rivals struggle to replicate.

The automotive retail industry operates as a fragmented oligopoly, with the top five public groups controlling roughly 50-60% of the organized market. ABG holds approximately 9.2% share, positioning it as a solid #5 player behind Lithia Motors (LAD) (18.8% share), Penske Automotive (PAG) (15.3%), AutoNation (AN) (14.0%), and Group 1 Automotive (GPI) (10-12%). This positioning matters because it defines ABG's strategic options: it lacks the procurement leverage of LAD's 300+ locations but compensates through regional density and superior per-store economics. While LAD can negotiate marginally better terms with OEMs, ABG's 97% increase in customer pay gross profit from 2014-2024 within its original stores demonstrates that operational execution trumps raw scale in driving profitability.

The industry faces three structural headwinds that reshape the investment landscape. First, SAAR remains stubbornly below historical norms at 16.2 million in 2025, with management projecting high-15 to low-16 million through 2027. This matters because it caps new vehicle volume growth, forcing retailers to compete on margin rather than scale. Second, vehicle affordability has collapsed, with new vehicle cost of sale exceeding $52,000 in Q4 2025—a 30% increase from pre-pandemic levels. This stretches consumer budgets and pressures front-end gross profits, making ABG's diversification into parts & service and F&I not just strategic but essential for survival. Third, the used vehicle supply remains constrained due to pandemic-era lease turn-in shortages, creating a supply-demand imbalance that ABG exploits by prioritizing gross profit over volume.

Technology, Products, and Strategic Differentiation

The Tekion DMS Heart Transplant

Asbury's transition from legacy CDK (CDK) to Tekion's cloud-based Dealer Management System represents more than a software upgrade—it's a fundamental re-architecting of store-level operations. By Q4 2025, 46 stores (over 25% of the portfolio) had converted, with the Koons Group fully migrated by Q2 2025. Management targets completion by Q3 2026, after which duplicate system costs disappear and productivity gains emerge.

The significance lies in the fact that legacy DMS platforms function as digital filing cabinets, requiring dealerships to bolt on dozens of third-party applications for CRM, inventory management, and F&I integration. This fragmentation creates integration fees, data silos, and productivity drag. Tekion's unified architecture eliminates these costs while providing real-time analytics and mobile-first workflows. The "heart transplant" analogy captures the pain: experienced employees face 6-7 month adaptation periods, and 2026 will bear the cost of running dual systems. But the payoff is structural—management anticipates significant SG&A savings and a flatter organization once fully deployed.

The implication is that ABG's 64.7% SG&A-to-gross-profit ratio in 2025 (up 66 basis points due to implementation costs) should compress toward 60% by 2027, directly expanding operating margins by 200-300 basis points. This isn't speculative; it's the culmination of a deliberate technology bet that larger peers, anchored to legacy systems, will struggle to replicate. While LAD and AN debate incremental digital features, ABG is rebuilding its operational backbone.

Total Care Auto: The F&I Platform Moat

Acquired in December 2021 for $285 million, TCA has evolved from a captive finance product provider into a scalable platform generating $326 million in 2025 revenue and $79.8 million in operating income (24.4% margin). TCA sells extended service contracts, prepaid maintenance, GAP, and appearance protection primarily through ABG's dealerships, but its economics differ fundamentally from traditional F&I.

The key insight lies in deferred revenue accounting. When TCA sells a product, it recognizes revenue over the contract life, creating a non-cash deferral that temporarily suppresses reported earnings. In Q4 2025, this deferral reduced F&I PVR by $105 to $2,335; without it, PVR would have been $2,440. This accounting treatment masks true profitability—TCA generated $12 million pretax income in Q4 while showing an $8 million non-cash deferral hit.

This matters because the deferral creates a timing mismatch that obscures TCA's earnings power. Management's original projection of $5.69 EPS accretion by 2029 has been revised down to $0.81 due to delayed Koons rollout (completed October 2025), lower SAAR assumptions (15.9M vs. 17M), and divestitures. However, the underlying math remains: each 1 million SAAR increase accelerates deferral recognition, while each new dealership added to the platform increases product flow. With Herb Chambers stores scheduled for TCA rollout in 2026, the platform gains 52 additional franchises, amplifying the flywheel.

TCA transforms ABG from a vehicle seller into a financial products platform. At scale, it could contribute $4.50-$5.50 per share by 2028-2029, representing 15-20% of total earnings. This diversifies revenue away from cyclical vehicle sales and creates recurring, high-margin income that commands a higher multiple. The risk is execution—delays in Tekion integration push back TCA rollout, and persistently low SAAR slows deferral recognition. But the moat is real: ABG owns the product provider, capturing margins that competitors cede to third parties.

Financial Performance & Segment Dynamics: Evidence of Strategy

Revenue Mix Shift Toward Stability

Consolidated revenue grew 4.7% to $18.0 billion in 2025, but the composition reveals strategic intent. New vehicles remain the largest revenue contributor at 52.8%, yet they generate only 20.2% of gross profit. Conversely, parts & service contribute just 13.9% of revenue but 47.9% of gross profit—a 58% gross margin business that grew 12% to $658 million in Q4 2025. This divergence matters because it shows ABG is optimizing for profit dollars, not revenue vanity metrics.

The Herb Chambers acquisition accelerates this shift. Chambers' luxury-heavy portfolio (BMW (BMW.DE), Mercedes (MBG.DE), Porsche (P911.DE)) commands higher PVRs and service retention rates. Luxury vehicles average 14.5 years on the road versus 12 years for mass-market, creating longer customer pay lifecycles. By increasing luxury mix from 32% to 36%, ABG is tilting its portfolio toward brands that generate 2-3x higher lifetime service revenue per customer.

ABG's gross profit margin compressed 9 basis points to 17.1% in 2025 due to new vehicle normalization, but the underlying mix shift provides downside protection. If SAAR contracts further, parts & service and TCA can offset new vehicle profit declines. This transforms ABG's earnings quality from cyclical to hybrid, justifying a higher multiple than traditional auto retailers.

New Vehicle Profitability: Managing the Decline

New vehicle gross profit per unit (PVR) declined from $3,611 in Q2 to $3,135 in Q4 2025, reflecting industry-wide margin normalization from pandemic peaks. Management maintains its $2,500-$3,000 stabilization target, but the path matters more than the destination. ABG's same-store new day supply fell from 59 days in Q2 to 49 days in Q4, indicating disciplined inventory management that avoids the margin-killing pressure of excess supply.

The Stellantis (STLA) performance illustrates ABG's operational edge: while national Stellantis sales fell 11.5% in Q2, ABG's volume rose 15.6%. This 27-percentage-point outperformance stems from superior inventory allocation and local market execution, not magic. ABG's regional density in the Southeast and Texas allows it to micro-target inventory to demand, while larger peers' national footprint creates coordination friction.

New vehicle PVRs will continue compressing toward $2,800, but ABG's inventory discipline and brand mix (luxury weighting from Chambers) should keep it at the high end of the range. This isn't a growth driver but a managed decline that frees capital for higher-return segments. The risk is misexecution—overstocking would force discounting that destroys gross profit dollars, but ABG's 49-day supply (vs. industry 52 days) suggests tight control.

Used Vehicle Strategy: Profit Over Volume

Used retail unit volume declined 8% in Q1 and remained constrained throughout 2025, yet gross profit per unit rose sequentially for four consecutive quarters, reaching $1,749 in Q4 (up 18% year-over-year). This counterintuitive performance reflects ABG's strategic pivot: with supply constrained, it prioritizes gross profit over market share. Over 85% of used inventory is sourced internally (trade-ins) versus auctions, the most profitable acquisition channel.

The average cost of used vehicles remains elevated above $30,000, limiting affordability and turn rate. ABG's response is to limit auction purchases and wait for the supply recovery expected in 2026-2028 as lease turn-ins normalize. This patience is economically rational: chasing volume at auction would compress margins and increase risk, while waiting preserves capital for the eventual supply inflection.

Used vehicle profitability is a timing game. ABG's discipline positions it to capture share when supply returns, but 2026 will remain challenging. The upside is substantial—each $500 reduction in average cost combined with maintained PVRs could add $50 million in annual gross profit. The risk is that competitors (especially Carvana's (CVNA) online model) capture younger buyers during the supply drought, permanently altering acquisition patterns.

Parts & Service: The Crown Jewel

Same-store parts & service gross profit grew 2% in Q4 2025 against high 13% customer pay and 26% warranty comps from 2024. The 58.1% gross margin expanded 13 basis points, and the fixed absorption rate exceeded 100%—meaning service profits alone cover all fixed costs. This is ABG's true competitive moat.

The aging vehicle fleet (14.5 years for cars, 12 years for trucks) creates a structural tailwind. Modern vehicle complexity—advanced driver assistance, hybrid powertrains, connected car systems—drives repair frequency and warranty work. ABG's 97% increase in customer pay gross profit from 2014-2024 in its original stores proves it can capture this trend. Western stores grew customer pay 14.4% in Q1 2025, showing geographic execution variance that the Tekion rollout will standardize.

Parts & service provides a $3.07 billion gross profit base that grows mid-single digits regardless of SAAR. This stability justifies a lower discount rate on ABG's cash flows and supports leverage reduction. The risk is technician capacity constraints—if ABG can't hire and train certified techs fast enough, it leaves profit on the table. But the 71,000-mile average customer pay ticket suggests strong retention.

Outlook, Management Guidance, and Execution Risk

Deleveraging and Capital Allocation

Management's top priority is reducing transaction-adjusted net leverage from 3.2x at year-end 2025 to below 3.0x by summer 2026. This timeline matters because it unlocks share repurchase capacity—$175.9 million remains authorized—and signals financial discipline to credit markets. The path is clear: $250-275 million in divestiture proceeds plus $465 million in 2025 free cash flow applied to debt achieves the target by mid-year.

The capital allocation framework is refreshingly pragmatic. If the share price remains attractive, buybacks take precedence; otherwise, debt paydown continues. This flexibility is crucial because ABG's 7.8x P/E and 0.97x book suggest the stock is attractive, but management must balance this against integration risks. The $250 million in planned 2026 capex (up from $186 million in 2025) reflects facility upgrades and Tekion completion, not empire-building.

ABG will be net debt-reducing through 2026, limiting acquisition activity to tuck-ins. This creates a "self-help" story where EPS growth comes from margin expansion and share count reduction rather than M&A. The risk is that competitors (LAD, GPI) use their higher multiples to acquire while ABG deleverages, potentially ceding market share. But ABG's 13.3% ROE suggests internal reinvestment yields superior returns.

SAAR and Macro Assumptions

Management's 2026 outlook assumes a "slightly backwards" SAAR in the high-15 to low-16 million range, with the first half "a little bit more of a struggle" and the second half "freeing up" as lease turn-ins increase used supply. This cautious stance reflects tariff uncertainty and affordability headwinds. The key insight is that ABG isn't betting on macro recovery—it's planning for continued pressure while optimizing internal levers.

The Stellantis tailwind is specific and measurable: ABG's Q2 volume outperformance of +15.6% vs. -11.5% national suggests its brand mix and regional presence create idiosyncratic growth drivers. Luxury brands (now 36% of mix) also show seasonal strength that smooths quarterly volatility.

ABG's guidance is achievable because it doesn't require macro help. The second-half improvement hinges on used supply recovery, which is largely demographic (lease maturities) rather than economic. The risk is that tariff-driven price increases on 2026 model-year vehicles further compress affordability, pushing SAAR toward 15 million and delaying recovery. But ABG's diversified profit base limits downside.

Tekion and TCA Rollout Execution

The Tekion completion target of Q3 2026 is aggressive but critical. Each quarter of delay pushes back SG&A savings and TCA integration. The Koons conversion in Q2 2025 provides a blueprint: 20 stores converted with manageable disruption, and by Q4 the group was operating normally. The Herb Chambers rollout in 2026 will be larger (52 franchises) but benefits from lessons learned.

TCA's revised EPS accretion timeline—delayed from $5.69 to $0.81 by 2029 due to lower SAAR—seems disappointing but masks the underlying math. The $5 target requires 17 million SAAR or additional acquisitions. At 15.9 million SAAR, accretion is slower but still compounding. The key is that TCA's value is path-dependent: it grows exponentially as more dealerships join and vehicle sales rise.

Execution risk is high but manageable. The Tekion "front-half hit, back-half benefit" dynamic means 2026 SG&A may rise before falling, pressuring margins. But successful completion creates a permanent cost advantage. TCA's delay is frustrating but doesn't invalidate the platform's value—it's a timing issue, not a structural flaw.

Risks and Asymmetries

The DMS Transition Risk

Tekion's "heart transplant" risks are real. The four-store pilot revealed "snafus" and 6-7 month employee adaptation periods. If the 2026 rollout encounters similar issues across 125+ remaining stores, SG&A could spike as productivity drops and duplicate costs persist beyond Q3 2026. This would delay margin expansion and potentially impact customer satisfaction.

A botched DMS transition doesn't just cost money—it disrupts the core revenue engine. If service scheduling, parts ordering, or F&I integration fails, same-store sales could decline. The $8.6 million in Tekion implementation costs in 2025 will likely double in 2026, and any material weakness in internal controls (like the Koons DMS issue in 2024) could trigger audit concerns.

This is a high-probability, moderate-impact risk. The likelihood of some disruption is 70%+, but ABG's experience with Koons and phased rollout mitigates severity. Investors should monitor same-store SG&A trends in Q1-Q2 2026—if SG&A-to-gross-profit doesn't peak by Q2, the timeline is slipping.

FTC Legal Overhang

The FTC initiated an administrative action in August 2024 regarding F&I practices, prompting ABG to file a lawsuit challenging the agency's authority. The proceedings remain pending with no loss range estimable. This creates regulatory uncertainty that could impact F&I profitability, which represents 23.4% of gross profit.

F&I is ABG's highest-margin segment (estimated 40-50% gross margins). If the FTC imposes restrictions on product pricing or disclosure, PVR could decline $200-400 per unit, reducing annual gross profit by $50-100 million. The legal challenge signals ABG's willingness to fight, but a negative outcome would materially impact the TCA investment thesis.

This is a low-probability, high-impact risk. The FTC's aggressive stance on auto retail is well-known, but ABG's practices are industry-standard. The bigger risk is reputational—prolonged litigation could distract management during the critical Tekion rollout. Investors should track case developments quarterly; any settlement involving material fines or business practice changes would require thesis reassessment.

Leverage and Liquidity Tightrope

Transaction-adjusted net leverage of 3.2x at year-end 2025 is above the 2.5-3.0x comfort zone. While management's summer 2026 sub-3.0x target is achievable, it requires flawless execution: $250+ million in divestiture proceeds, $450+ million in free cash flow, and no major operational disruptions. Liquidity of $927 million provides cushion, but $3.59 billion in debt (excluding floor plan) means interest expense consumes 38% of operating income.

Auto retail is cyclical, and entering a downturn with elevated leverage amplifies downside. If SAAR falls to 15 million and new vehicle margins compress further, EBITDA could decline 10-15%, pushing leverage toward 4.0x and limiting financial flexibility. The $175.9 million buyback authorization would be shelved, and covenant compliance could become an issue.

This is a moderate-probability, high-impact risk in a recession scenario. ABG's current ratios (0.95 current, 0.18 quick) are tight but typical for auto retail. The key is free cash flow conversion—if working capital becomes a use rather than source of cash during a downturn, deleveraging stalls. Investors should monitor monthly SAAR and ABG's days supply; inventory bloat would signal trouble.

Upside Asymmetry: TCA and Portfolio Quality

If Tekion completes on schedule and TCA rolls out to Herb Chambers by year-end 2026, ABG could exceed its $5 EPS target even at 16 million SAAR. The math: 52 new franchises × 1,000 units/year × $2,500 F&I PVR × 40% margin = $52 million incremental operating income. Combined with $30-40 million in Tekion SG&A savings, this adds $1.50-2.00 in EPS by 2027.

The divestiture program's quality improvement is undervalued. Exiting California, Colorado, and other challenged markets reduces exposure to regulatory risk and low-margin volume, while the Northeast luxury concentration provides defensive characteristics. Luxury customers are less interest-rate sensitive and generate 3x service revenue over vehicle life.

The upside case isn't dependent on macro recovery but on internal execution. If ABG hits its leverage target and resumes buybacks, the share count reduction alone could add $0.50-0.75 to EPS in 2026. The market is pricing in zero execution success, creating meaningful asymmetry.

Valuation Context

At $195.56 per share, ABG trades at 7.8x trailing earnings and 6.6x free cash flow—multiples that imply a cyclical business in permanent decline. Yet the company generated $465 million in free cash flow in 2025 (26% of market cap) and maintains a 13.3% ROE with manageable leverage (1.57x debt-to-equity). This disconnect suggests the market views auto retail as a melting ice cube, ignoring ABG's portfolio transformation and technology catalyst.

Peer comparisons highlight the anomaly. AutoNation trades at 11.3x earnings with 2.35% profit margin and 4.37x leverage—inferior operational metrics yet a 45% valuation premium. Group 1 trades at 12.9x earnings with 1.44% profit margin. Only Lithia (7.75x) trades similarly, but its 1.20 beta and acquisition-driven growth profile carry higher risk. ABG's 0.77 beta and 0.97x price-to-book (vs. AN's 2.89x) suggest the market assigns no value to its real estate or franchise rights.

The EV/EBITDA multiple of 9.06x is below the 10-11x range typical for auto retail during mid-cycle periods, reflecting pessimism about earnings sustainability. However, if Tekion delivers $30 million in SG&A savings and TCA contributes $50 million in incremental operating income by 2027, EBITDA could approach $1.2 billion, making the pro forma multiple 7.5x—a clear discount for a transformed business.

Valuation is pricing zero execution success. The stock offers a 13% earnings yield with no dividend, making it a pure play on management's ability to deliver technology savings and deleverage. If the thesis plays out, multiple expansion to 10x earnings would imply a $250+ stock price. If execution fails, downside is cushioned by 0.97x book value and $465 million in annual free cash flow.

Conclusion: The Self-Help Story at Cyclical Bottom

Asbury Automotive is executing a strategic transformation that the market has yet to recognize. The Herb Chambers acquisition and concurrent divestitures aren't random portfolio shuffling—they're deliberate moves to concentrate in higher-margin, more resilient luxury markets while accelerating deleveraging. The Tekion DMS transition, while painful in 2026, promises permanent SG&A savings that reinforce ABG's historical operational leadership. Combined with a parts & service business generating nearly half of gross profit and a TCA platform adding high-margin F&I revenue, ABG is evolving from a cyclical auto retailer into a diversified automotive services company.

The investment thesis hinges on execution, not macro recovery. Management's guidance for sub-3.0x leverage by summer 2026 is achievable through divestiture proceeds and free cash flow, unlocking share repurchases at attractive valuations. The Tekion rollout's "front-half hit, back-half benefit" dynamic creates a clear catalyst timeline: margin pressure through Q2 2026, followed by savings and productivity gains in 2027. TCA's delayed EPS accretion is frustrating but path-dependent on SAAR recovery and dealership integration, both of which are largely within management's control.

Trading at 7.8x earnings with 13.3% ROE and $465 million in free cash flow, ABG offers compelling risk/reward. The downside is cushioned by tangible book value and defensive revenue mix, while upside from technology savings, portfolio optimization, and TCA scaling could drive 30-40% earnings growth by 2027. The market sees a cyclical auto retailer; investors should see a self-help transformation story at the bottom of the cycle. The next 12 months will determine whether ABG emerges as a re-rated services platform or remains a discounted cyclical—making execution the only variable that matters.